WSJ News Exclusive | Novartis Pursuit of Cytokinetics Cools

Updated Jan. 11, 2024 12:47 pm ET Novartis has backed away from its pursuit of Cytokinetics,…

WSJ News Exclusive | Novartis in Advanced Talks to Buy Cytokinetics

Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug, as pharmaceutical…

A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?

In pharma, you can take a larger slice of the healthcare pie than your peers, but…

Big Pharma’s Battle With the Biden Administration Could Have Legs

Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the…

Get In on This Skin Disease Drug Before Big Pharma Does

What to Read Next